Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Black Hawk Acquisition Corp

NASDAQ: BKHA · Life Sciences · 4 alerts · CIK 2000775

Share price
$7.20Close, Nov 16
Market cap
$29.9M
Shares outstanding
4.15MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Black Hawk Acquisition Corp filings on SEC EDGAR ↗

4:17 PM ET 8-K
M&A Deal

Black Hawk Acquisition M&A Deal with Vesicor Therapeutics, Inc.

Black Hawk Acquisition Corporation shareholders approved its business combination with Vesicor Therapeutics, Inc. at an extraordinary general meeting. The approval includes the domestication of the company from the Cayman Islands to Delaware and the election of five directors to the post-combination board. This represents a status update on a pending merger as the SPAC moves toward closing the transaction.

Counterparty
Vesicor Therapeutics, Inc.
4:16 PM ET 8-K
M&A Deal

Black Hawk Acquisition M&A Deal with Vesicor Therapeutics, Inc.

Black Hawk Acquisition Corp entered into a forward purchase agreement and subscription agreement with Meteora Select Trading Opportunities Master, LP to support its pending business combination with Vesicor Therapeutics. The agreement covers up to 1,350,000 shares and includes an OTC equity prepaid forward transaction to manage redemption levels and provide financing for the merger. Upon closing, the company will pay a prepayment amount from its trust account to Meteora based on the redemption price of the shares.

Counterparty
Vesicor Therapeutics, Inc.
Term
36 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.